Vimarsana.com

Latest Breaking News On - Hhlr advisors - Page 2 : vimarsana.com

Sanford C. Bernstein Raises PDD (NASDAQ:PDD) Price Target to $235.00

PDD (NASDAQ:PDD – Free Report) had its target price raised by Sanford C. Bernstein from $180.00 to $235.00 in a report published on Thursday morning, Benzinga reports. Sanford C. Bernstein currently has an outperform rating on the stock. PDD has been the subject of several other reports. Barclays raised their price target on PDD from […]

Sanfordc-bernstein
Baillie-gifford-co
Jefferies-financial-group
Hhlr-advisors
Jpmorgan-chase-co
Barclays
Vanguard-group-inc
Goldman-sachs-group
Holdings-inc
Sc-us-ttgp
Free-report

PDD (NASDAQ:PDD) Shares Gap Up Following Analyst Upgrade

PDD Holdings Inc. (NASDAQ:PDD – Get Free Report)’s stock price gapped up prior to trading on Friday after Barclays raised their price target on the stock from $178.00 to $224.00. The stock had previously closed at $153.63, but opened at $158.89. Barclays currently has an overweight rating on the stock. PDD shares last traded at […]

United-states
America
Sanfordc-bernstein
Pdd-holdings-inc
Company-profile
Hhlr-advisors
Baillie-gifford-co
Holdings-inc
Nasdaq
Sc-us-ttgp
Goldman-sachs-group

PDD (NASDAQ:PDD) Price Target Raised to $198.00

PDD (NASDAQ:PDD – Free Report) had its target price boosted by Citigroup from $185.00 to $198.00 in a research report sent to investors on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research firms have also recently weighed in on PDD. Jefferies Financial Group boosted their price […]

Hhlr-advisors
Vanguard-group-inc
Sc-us-ttgp
Jefferies-financial-group
Goldman-sachs-group
Baillie-gifford-co
Holdings-inc
Barclays
Citigroup
Free-report
Financial-group

Metagenomi's (MGX) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $10.00 price objective on the stock. HC Wainwright also issued estimates for Metagenomi’s Q2 2024 earnings at ($0.69) EPS, Q3 2024 earnings at ($0.71) […]

United-states
Vanguard-group-inc
Wells-fargo-company
Jefferies-financial-group
Metagenomi-company-profile
Hhlr-advisors
Jpmorgan-chase-co
Artal-group
Altitude-crest-partners-inc
Metagenomi-inc
Free-report

Meta Platforms, Inc. (NASDAQ:META) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Meta Platforms, Inc. (NASDAQ:META – Get Free Report) have been assigned an average rating of “Moderate Buy” from the forty-four brokerages that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, three have given a hold recommendation, thirty-seven have given a buy recommendation and […]

Canada
Raymond-james
Javier-olivan
Nicholas-clegg
Securities-exchange-commission
Nasdaq
Cloverfields-capital-group
Hhlr-advisors
Instagram
Meta-platforms-company-profile
Evergreen-quality-fund-gp-ltd
Meta-platforms-inc

vimarsana © 2020. All Rights Reserved.